SCHEDULE 13G: State Street Corporation Discloses 4.4% Passive Stake in Intellia Therapeutics

State Street Corporation has reported a passive beneficial ownership of 4.4% in Intellia Therapeutics Inc., holding 4,510,261 shares of common stock as of March 31, 2025.

Summary

• State Street Corporation, a parent holding company, has filed a Schedule 13G indicating its beneficial ownership in Intellia Therapeutics Inc.
• As of March 31, 2025, State Street Corporation beneficially owns 4,510,261 shares of Intellia Therapeutics Inc. common stock.
• This ownership represents 4.4% of the total class of securities.
• State Street Corporation holds shared voting power over 4,190,987 shares and shared dispositive power over 4,510,261 shares.
• The filing confirms that the securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Intellia Therapeutics Inc.
• The beneficial ownership is held through various subsidiaries, including SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, State Street Global Advisors, Australia, Limited, and State Street Global Advisors, Ltd.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing (Schedule 13G) by an institutional investor, indicating a passive ownership stake. It does not contain information that would typically alter the fundamental sentiment towards the issuer, Intellia Therapeutics Inc., but rather confirms its inclusion in institutional portfolios.

Positives

• State Street Corporation, a major institutional investor, holds a significant passive stake, indicating the company's inclusion in various investment portfolios managed by State Street's subsidiaries.

Negatives

• The reported stake of 4.4% is below the 5% threshold that would typically trigger more detailed reporting or suggest a more active investment strategy.

Risks

• The filing explicitly states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control, meaning State Street Corporation is a passive investor and will not actively engage in corporate governance or strategic decisions.

Future Outlook

NA

Industry Context

State Street Corporation is one of the world's largest institutional asset managers, and its filing of a Schedule 13G for Intellia Therapeutics Inc. is typical for a company included in various passive investment vehicles, such as index funds or ETFs, managed by State Street's subsidiaries. This indicates Intellia Therapeutics' presence in broader market indices or investment strategies.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake.
• Investment Professionals: Confirms Intellia Therapeutics' presence in institutional portfolios, potentially influencing its liquidity and market perception.

Key Dates

Keywords

Intellia Therapeutics, State Street Corporation, Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, SEC filing, asset management